SCHEMBL6037582

SCHEMBL6037582

C[C@H]1CNC(C(=O)O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22269 1.00
SCHEMBL2184624 1.00
SCHEMBL1355142 1.00
SCHEMBL19521748 1.00
SCHEMBL22270 1.00
SCHEMBL1355800 1.00
SCHEMBL31416087 1.00
SCHEMBL2184981 1.00
Hydrochloric Acid SCHEMBL25230162 0.98 CYP2D6 (0.56)
Hydrochloric Acid SCHEMBL26120219 0.98 CYP2D6 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873291-B2 Quinoline cGAS antagonist compounds IMMUNESENSOR THERAPEUTICS, INC. (US) 2024-01-16 US disclosed
US-11873291-B2 Quinoline cGAS antagonist compounds IMMUNESENSOR THERAPEUTICS, INC. (US) 2024-01-16 US disclosed
US-9422566-B2 Gene cluster for biosynthesis of griselimycin and methylgriselimycin SANOFI (FR) 2016-08-23 US disclosed
US-20140295457-A1 GENE CLUSTER FOR BIOSYNTHESIS OF GRISELIMYCIN AND METHYLGRISELIMYCIN SANOFI (FR) 2014-10-02 US disclosed
US-20060183888-A1 Pyrrolysine synthesis and modification NIH - DEITR 2006-08-17 US disclosed
US-20060166319-A1 Charging tRNA with pyrrolysine NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-07-27 US disclosed